# Burden of Disease Among Subjects With Eosinophilic Chronic Obstructive Pulmonary Disease (COPD)

> **NCT03436511** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 341 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03436511
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-05
- **Primary completion:** 2018-10-31
- **Final completion:** 2018-12-10
- **Target enrollment:** 341 (ACTUAL)
- **Last updated:** 2019-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03436511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03436511, "Burden of Disease Among Subjects With Eosinophilic Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03436511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*